FDA Drug recall D-1269-2020
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Av…
- FDA Drug
- Class I
- terminated
- Published 2020-05-20
On 2020-05-20 the FDA classified a Class I recall of Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Av… by Masterpharm, citing cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1269-2020 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2020-04-14 |
| Published | 2020-05-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Masterpharm |
| Distribution | US |
Product
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Reason
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Identifiers
| code_info | Lot #02-27-2020:04@11, Exp. August 25, 2020. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1269-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.